Q3 FY2026 · ended Sep 30, 2026 · Revenue $691.50M, -1.4% YoY · Filed Oct 29, 2026
Fortrea Holdings Inc. (FTRE) files with the SEC under industry code 8071, Services-Medical Laboratories. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $691.5 million and net income of $600,000. Free cash flow was $52.5 million. As of Sep 30, 2026 it held $220.6 million in cash and investments and $1.1 billion in total debt.
Revenue
$691.50M
-1.4% vs year-ago quarter
Net income
$600,000
+103.8% vs year-ago quarter
Operating cash flow
$60.80M
-30.0% vs year-ago quarter
Free cash flow
$52.50M
-34.0% vs year-ago quarter
EPS
$0.01
+105.9% vs year-ago quarter
Dividend per share
None
Shares outstanding
96.50M
+4.4% vs year-ago quarter
Net cash
$-897.80M
Q3 FY2026
Operating margin
0.5%
TTM
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- FTRE (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Durham, NC
- SEC filer status
- Accelerated filer
- SEC CIK
- 1965040
- Former names
- Silver Spinco Inc. (until Apr 5, 2023)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $691.5M | $678.2M | $636.5M | $660.5M | $701.3M |
| Operating income | $15.0M | $14.8M | -$3.4M | -$13.6M | -$8.6M |
| Net income | $600,000 | -$13.2M | -$23.6M | -$32.5M | -$15.9M |
| Diluted EPS | $0.01 | -$0.14 | -$0.25 | — | -$0.17 |
| Operating cash flow | $60.8M | $28.9M | -$17.0M | $129.1M | $86.8M |
| Free cash flow | $52.5M | $19.9M | -$25.0M | $121.6M | $79.5M |
| Total assets | $2.7B | $2.7B | $2.7B | $2.7B | $2.7B |
| Total liabilities | $2.2B | $2.2B | $2.2B | $2.2B | $2.2B |
| Stockholders' equity | $532.3M | $524.2M | $525.9M | $563.5M | $580.8M |
| Cash and investments | $220.6M | $168.6M | $147.5M | $174.6M | $131.3M |
| Total debt | $1.1B | $1.1B | $1.1B | $1.1B | $1.2B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 10, 2026 | Sep 9, 2026 |
| 10-Q | Quarterly report | Jul 29, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Jul 29, 2026 | Jul 27, 2026 |
All 338 Fortrea Holdings Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.